The incidence and risk of cardiac events in patients with previously treated multiple myeloma vs. matched patients without multiple myeloma: an observational, retrospective, cohort study

Conclusions This study provides the first known comparison of cardiac event risk in MM patients vs. age- and gender-matched patients without MM. Cardiac event risk was greater in MM patients with ≥3 prior drugs for any cardiac event, dysrhythmias, CHF, cardiomyopathy, and conduction disorders compared to patients with non-MM. Teaser This study provides a unique look at real world cardiac event rates for a large group of MM patients treated with selected anti-myeloma treatments. Cardiac event risk for any cardiac event including hypertensive/arterial events, cardiac dysrhythmias, CHF, IHD, cardiomyopathy, and conduction disorders was greater in MM patients with ≥3 prior drugs (n=1,723) compared to patients without MM (n=8,615).
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research